학술논문

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort
Document Type
Article
Source
Leukemia; December 2023, Vol. 37 Issue: 12 p2497-2501, 5p
Subject
Language
ISSN
08876924; 14765551